[Chronic cardiac failure in noncoronarogenic myocardial diseases and refracterin effects].
Paleev
N R
NR
Sanina
N P
NP
Paleev
F N
FN
Pronina
V P
VP
Sukoian
G V
GV
Karsanov
N V
NV
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001706:Biopsy; D009202:Cardiomyopathies / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D002908:Chronic Disease; D003574:Cytochrome c Group / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007288:Inosine / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009243:NAD / Q000494:pharmacology / Q000627:therapeutic use; D010099:Oxyfedrine / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D003574:Cytochrome c Group; D004338:Drug Combinations; D009243:NAD; D007288:Inosine; D010099:Oxyfedrine